Generating EngTregs to Overcome Key Challenges Associated with the Successful Application of Treg Cell Therapeutics
Time: 11:30 am
day: Day Two
Details:
- Engineering abundant T cell populations with stabilized FOXP3 expression to create a scalable Treg Phenotype
- Utilizing an inducible chimeric receptor to provide highly specific and tunable IL-2 signaling support
- Providing tissue specificity and enhanced regulatory functions through antigenspecific CARs or TCRs
